Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENSO 16 vs Glucose in Healthy Subjects
NCT05457400Phase 1Completed
- Sponsor
- Alpha Republic GmbH
- Start
- Apr 2022
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Alpha Republic GmbH. Primary endpoint: Area Under the Curve of Plasma Glucose. Started Apr 2022; status: completed.
Beyond the preview
Go deeper on NCT05457400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05457400.